Key facts
- Loop Dee Science’s last known valuation is $7.6M (May 2025).
- It has raised $3.5M; the latest was Later Stage VC ($1.2M) in May 2025.
- Notable investors include GO Capital, Algimo, Crédit Agricole Aquitaine, NORMANDIE, Normandie Business Angels — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Loop Dee Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Loop Dee Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Loop Dee Science
Developer of detection kits designed to make molecular biology diagnostics accessible to people. The company uses amplification technology and the creation of tools allowing the automation of these tests and also offers genetic analysis kits allowing the detection of DNA and RNA of pathogens, enabling customers to have a technology for diagnostics in molecular biology.
- Sector
- Healthcare
- HQ
- Bretteville-sur-Odon, France
- Founded
- 2017
- Employees
- 12
- Website
- loopdeescience.com/
- Ownership
- Privately Held (backing)
Loop Dee Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Loop Dee Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Loop Dee Science in its N-PORT filings yet. We sweep new filings monthly.